HZNP - Horizon Pharma Public Limited Company

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
15.00
+0.16 (+1.08%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close14.84
Open14.84
Bid13.62 x 100
Ask15.29 x 100
Day's Range14.66 - 15.11
52 Week Range9.45 - 18.31
Volume3,505,852
Avg. Volume2,407,688
Market Cap2.458B
Beta0.72
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Stocks With Rising Relative Price Strength: Horizon Pharma
    Investor's Business Daily2 days ago

    Stocks With Rising Relative Price Strength: Horizon Pharma

    Horizon Pharma sees its Relative Strength Rating move into the 80-plus level.

  • Horizon Pharma Earns RS Rating Upgrade
    Investor's Business Daily3 days ago

    Horizon Pharma Earns RS Rating Upgrade

    Horizon Pharma shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Market Realist5 days ago

    Analysts’ Recommendations for BioMarin in December 2017

    In October 2017, the FDA granted BioMarin's valoctocogene roxaparvovec its Breakthrough Therapy Designation.

  • Capital Cube13 days ago

    ETFs with exposure to Horizon Pharma Plc : December 4, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Horizon Pharma Plc Here are 5 ETFs with the largest exposure to HZNP-US. Comparing the performance and risk of Horizon Pharma Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Horizon Pharma PLC.
    Markit20 days ago

    See what the IHS Markit Score report has to say about Horizon Pharma PLC.

    Short interest is low for HZNP with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $2.68 billion over the last one-month into ETFs that hold HZNP are not among the highest of the last year and have been slowing.

  • Capital Cube23 days ago

    ETFs with exposure to Horizon Pharma Plc : November 24, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Horizon Pharma Plc Here are 5 ETFs with the largest exposure to HZNP-US. Comparing the performance and risk of Horizon Pharma Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Horizon Pharma PLC.
    Markit25 days ago

    See what the IHS Markit Score report has to say about Horizon Pharma PLC.

    Short interest is low for HZNP with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding HZNP are favorable, with net inflows of $3.35 billion.

  • Capital Cubelast month

    ETFs with exposure to Horizon Pharma Plc : November 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Horizon Pharma Plc Here are 5 ETFs with the largest exposure to HZNP-US. Comparing the performance and risk of Horizon Pharma Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Horizon Pharma Plc :HZNP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 10, 2017
    Capital Cubelast month

    Horizon Pharma Plc :HZNP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 10, 2017

    Categories: Yahoo FinanceGet free summary analysis Horizon Pharma Plc reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Horizon Pharma Plc – Amgen Inc., Aralez Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Radius Health Inc, Alder Biopharmaceuticals, Inc., Merck & Co., Inc. and Pfizer Inc. ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Horizon Pharma PLC.
    Markitlast month

    See what the IHS Markit Score report has to say about Horizon Pharma PLC.

    Short interest is low for HZNP with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $2.84 billion over the last one-month into ETFs that hold HZNP are not among the highest of the last year and have been slowing.

  • Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : November 10, 2017
    Capital Cubelast month

    Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : November 10, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Horizon Pharma Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of HZNP earnings conference call or presentation 6-Nov-17 1:00pm GMT

    Q3 2017 Horizon Pharma PLC Earnings Call

  • Horizon Pharma (HZNP) Tops Q3 Earnings & Sales, Ups View
    Zackslast month

    Horizon Pharma (HZNP) Tops Q3 Earnings & Sales, Ups View

    Horizon Pharma (HZNP) Q3 results were driven by growth from the orphan and rheumatology business.

  • TheStreet.comlast month

    Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

    The Dublin firm on Nov. 6 unveiled third-quarter numbers that topped analysts' estimates and raised its full-year net sales outlook and the lower end of its 2017 adjusted Ebitda guidance.

  • Horizon (HZNP) Tops Q3 Earnings, Shares Up
    Zackslast month

    Horizon (HZNP) Tops Q3 Earnings, Shares Up

    Horizon Pharma (HZNP) topped earnings and sales in the third quarter. Consequently, share are trading up in pre-market trading.

  • How Financially Strong Is Horizon Pharma Public Limited Company (HZNP)?
    Simply Wall St.last month

    How Financially Strong Is Horizon Pharma Public Limited Company (HZNP)?

    Stocks with market capitalization between $2B and $10B, such as Horizon Pharma Public Limited Company (NASDAQ:HZNP) with a size of USD $2.31B, do not attract as much attention from theRead More...

  • Key Predictions for Q3 Earnings Reports of MYL, HZNP & KERX
    Zackslast month

    Key Predictions for Q3 Earnings Reports of MYL, HZNP & KERX

    The pharma/biotech industry has witnessed strong Q3 results with many companies beating estimates for earnings and sales. Let's see if generic maker Mylan and other small companies follow suit.

  • Horizon Pharma (HZNP) Q3 Earnings: A Disappointment in Store? (revised)
    Zackslast month

    Horizon Pharma (HZNP) Q3 Earnings: A Disappointment in Store? (revised)

    Horizon Pharma???s shares have declined 12% in the year so far, underperforming the industry???s gain of 0.9%.

  • Capital Cube2 months ago

    ETFs with exposure to Horizon Pharma Plc : October 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Horizon Pharma Plc Here are 5 ETFs with the largest exposure to HZNP-US. Comparing the performance and risk of Horizon Pharma Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Horizon Pharma Plc breached its 50 day moving average in a Bullish Manner : HZNP-US : October 3, 2017
    Capital Cube2 months ago

    Horizon Pharma Plc breached its 50 day moving average in a Bullish Manner : HZNP-US : October 3, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Horizon Pharma Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Horizon Pharma Public Limited Company (HZNP): How Does It Impact Your Portfolio?
    Simply Wall St.2 months ago

    Horizon Pharma Public Limited Company (HZNP): How Does It Impact Your Portfolio?

    If you are a shareholder in Horizon Pharma Public Limited Company’s (NASDAQ:HZNP), or are thinking about investing in the company, knowing how it contributes to the risk and reward profileRead More...

  • Capital Cube3 months ago

    ETFs with exposure to Horizon Pharma Plc : September 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Horizon Pharma Plc Here are 5 ETFs with the largest exposure to HZNP-US. Comparing the performance and risk of Horizon Pharma Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Is Horizon Pharma (HZNP) A Suitable Pick for Value Investors?
    Zacks3 months ago

    Is Horizon Pharma (HZNP) A Suitable Pick for Value Investors?

    Let's find out if Horizon Pharma Public Limited Company (HZNP) stock is a good choice for value-oriented investors right now

  • Reuters3 months ago

    Horizon Pharma weighs sale of primary care unit -sources

    Specialty drugmaker Horizon Pharma PLC is working with investment bank Morgan Stanley to review strategic options for its primary care drugs business, including a potential sale of the unit, people familiar with the matter said on Friday. Dublin-based Horizon is in talks with a number of parties interested in acquiring the asset, expected to generate annual revenue of $350 million in sales in 2017, according to the people, who asked not to be named because the discussions are private. Horizon declined to comment.

  • Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : September 14, 2017
    Capital Cube3 months ago

    Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : September 14, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Horizon Pharma Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)